Table 3. Odds of achieving normoglycemia among Resist Diabetes trial participants.a.
| Parameter | Coefficient (SE) | OR | 95% CI | Interpretation |
|---|---|---|---|---|
| Phase | ||||
| SCT Group | ||||
| Initiation | Ref | 1.00 | ||
| Maintenance (M 9) | 0.11 (0.31) | 1.12 | (0.61, 2.04) | |
| No-Contact (M 15) | -0.11 (0.33) | 0.90 | (0.47, 1.70) | |
| STD Group | ||||
| Initiation | -0.03 (0.35) | 0.97 | (0.49, 1.94) | |
| Maintenance (M 9) | -0.31 (0.37) | 0.74 | (0.35, 1.53) | |
| No Contact (M 15) | -0.26 (0.38) | 0.77 | (0.36, 1.63) | |
| Δ in Lean Mass Percentb | 0.18 (0.08) * | 1.19 | (1.02, 1.39) | The odds of reverting to normoglycemia are higher for participants with an increase in lean body mass percentage. |
| Gender | ||||
| Male | Ref | 1.00 | ||
| Female | -0.37 (0.30) | 0.69 | (0.38, 1.24) | |
| Prediabetes Phenotype | ||||
| IFG and IGT | Ref | 1.00 | ||
| IFG | 1.27 (0.32) ** | 3.58 | (1.93, 6.63) | Participants with isolated IFG and isolated IGT have higher odds of reverting to normoglycemia compared to those with both IFG & IGT. |
| IGT | 1.59 (0.43) ** | 4.92 | (2.13, 11.34) | |
| Intercept | -1.34 (0.39) ** | 0.26 | (0.12, 0.56) |
NInitiation = 159; NMaintenance = 138; NNo Contact = 129; Number of observations used in analyses = 422.
Abbreviations: CI, confidence interval; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; M, month; OR, odds ratio; SCT, Social Cognitive Theory; STD, standard.
a Population-averaged Generalized Estimation Model.
b Within-Person change from Baseline to 15 Months.
* p<0.05
** p<0.01.